The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes (Edu4U)
Primary Purpose
Diabetes Mellitus, Type 1
Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
text message to parent only
text message to parent and adolescent
Sponsored by
About this trial
This is an interventional supportive care trial for Diabetes Mellitus, Type 1
Eligibility Criteria
Inclusion Criteria:
- Be willing to agree to participate(assent) in the study and have the permission of the parent to do so.
- Have a diagnosis of Type 1 diabetes for ≥ one year.
- Be aged 8 to 18 years old.
- Be on insulin therapy for ≥ one year.
- Have a parent/legal guardian with access to a working cell phone or have a parent/legal guardian with access to a working cell phone and have a working cell phone (if 13 years of age or older).
- Utilize one of the following mobile carriers: T-Mobile, Sprint, Verizon, AT&T, or Virgin Mobile.
- The parent/legal guardian must express intent to maintain a carrier plan for the duration of the study.
- The parent/legal guardian must be able to read English OR the parent/legal guardian and the adolescent must be able to read English.
Exclusion Criteria:
- Participants, who in the opinion of the investigator, have any contraindication to tight glycemic control.
- Individuals who are unable to undertake blood glucose testing during the study period
- Individuals who are deemed unable or unlikely to comply with the protocol.
Sites / Locations
- University of Louisville
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Active Comparator
Active Comparator
No Intervention
Arm Label
8-12 years old, parent receiving text
13-18 years old, parent receiving text
13-18 years, both receiving text
No text
Arm Description
text message to parent only
text message to parent only
Text message to parent and adolescent
No text will be sent
Outcomes
Primary Outcome Measures
glycemic control assessed by HbA1C level.
review of lab value
Secondary Outcome Measures
number of episodes of Diabetic Ketoacidosis (DKA)
chart review of self reported episodes of Diabetic Ketoacidosis and chart review of hospitalizations related to DKA
number of episodes of severe hypoglycemia
chart review of reported episodes of severe hypoglycemia and chart review of hospitalizations related to hypoglycemia
number of patient contacts to the diabetes educator
chart review of educator documentation of communication with subject
number of hospitalizations related to T1D
chart review of hospitalizations related to T1D
Full Information
NCT ID
NCT02619487
First Posted
June 8, 2015
Last Updated
December 13, 2018
Sponsor
University of Louisville
1. Study Identification
Unique Protocol Identification Number
NCT02619487
Brief Title
The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes
Acronym
Edu4U
Official Title
The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes
Study Type
Interventional
2. Study Status
Record Verification Date
December 2018
Overall Recruitment Status
Withdrawn
Why Stopped
Due to limited staff resources, we were unable to start enrolling participants.
Study Start Date
March 2019 (Anticipated)
Primary Completion Date
December 13, 2019 (Anticipated)
Study Completion Date
December 13, 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Louisville
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine whether a simple text message reminder sent to the parent of an child/adolescent with Type 1 Diabetes(or parent and adolescent) is effective in helping the individual(or parent) become more compliant with self-managing the Type 1 Diabetes (T1D). There will be 5 arms: text message sent to parents of children age 8-12 years old with T1D, text messages sent to parents of adolescents ,age 13-18 years old, with T1D,text messages sent to parents of adolescents with T1D as well as the adolescent with T1D,no text message sent to parents of children age 8-12 years, and no text message sent to adolescents or parents of adolescents age 13-18 years old.
Detailed Description
Managing Type 1 Diabetes requires daily checks of blood glucose and medication adjustments. Children and adolescents are known to have more difficulty with this than adults. Parents/legal guardians also face the task of helping with this self-management. A weekly text message regarding Type 1 Diabetes, sent to the parent or the parent and adolescent, may help to remind and motivate an individual to perform the daily tasks needed to manage their Type 1 Diabetes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 1
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
8-12 years old, parent receiving text
Arm Type
Experimental
Arm Description
text message to parent only
Arm Title
13-18 years old, parent receiving text
Arm Type
Active Comparator
Arm Description
text message to parent only
Arm Title
13-18 years, both receiving text
Arm Type
Active Comparator
Arm Description
Text message to parent and adolescent
Arm Title
No text
Arm Type
No Intervention
Arm Description
No text will be sent
Intervention Type
Other
Intervention Name(s)
text message to parent only
Other Intervention Name(s)
e-health intervention
Intervention Description
A weekly text message of an educational or motivational nature and related to Type 1 Diabetes will be sent for a duration of one year
Intervention Type
Other
Intervention Name(s)
text message to parent and adolescent
Intervention Description
A weekly text message of an educational or motivational nature and related to Type 1 Diabetes will be sent for a duration of one year
Primary Outcome Measure Information:
Title
glycemic control assessed by HbA1C level.
Description
review of lab value
Time Frame
up to one year after randomization occurs
Secondary Outcome Measure Information:
Title
number of episodes of Diabetic Ketoacidosis (DKA)
Description
chart review of self reported episodes of Diabetic Ketoacidosis and chart review of hospitalizations related to DKA
Time Frame
up to one year after randomization occurs
Title
number of episodes of severe hypoglycemia
Description
chart review of reported episodes of severe hypoglycemia and chart review of hospitalizations related to hypoglycemia
Time Frame
up to one year after randomization occurs
Title
number of patient contacts to the diabetes educator
Description
chart review of educator documentation of communication with subject
Time Frame
up to one year after randomization occurs
Title
number of hospitalizations related to T1D
Description
chart review of hospitalizations related to T1D
Time Frame
up to one year after randomization occurs
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Be willing to agree to participate(assent) in the study and have the permission of the parent to do so.
Have a diagnosis of Type 1 diabetes for ≥ one year.
Be aged 8 to 18 years old.
Be on insulin therapy for ≥ one year.
Have a parent/legal guardian with access to a working cell phone or have a parent/legal guardian with access to a working cell phone and have a working cell phone (if 13 years of age or older).
Utilize one of the following mobile carriers: T-Mobile, Sprint, Verizon, AT&T, or Virgin Mobile.
The parent/legal guardian must express intent to maintain a carrier plan for the duration of the study.
The parent/legal guardian must be able to read English OR the parent/legal guardian and the adolescent must be able to read English.
Exclusion Criteria:
Participants, who in the opinion of the investigator, have any contraindication to tight glycemic control.
Individuals who are unable to undertake blood glucose testing during the study period
Individuals who are deemed unable or unlikely to comply with the protocol.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gwendolyn S Pierce, MSN
Organizational Affiliation
University of Louisville
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Louisville
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes
We'll reach out to this number within 24 hrs